Skip to main content

Market Overview

Recap: AngioDynamics Q3 Earnings



Shares of AngioDynamics (NASDAQ:ANGO) remained unaffected after the company reported Q3 results.

Quarterly Results

Earnings per share were up 100.00% year over year to $0.02, which beat the estimate of ($0.02).

Revenue of $71,182,000 rose by 2.01% year over year, which beat the estimate of $68,950,000.


The upcoming fiscal year's EPS expected to be between $0.04 and $0.06.

The upcoming fiscal year's revenue expected to be between $285,000,000 and $288,000,000.

How To Listen To The Conference Call

Date: Mar 30, 2021

Time: 08:00 AM

ET Webcast URL:

Price Action

52-week high: $23.40

Company's 52-week low was at $8.05

Price action over last quarter: Up 12.20%

Company Description

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.


Related Articles (ANGO)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at